Importantly, ChIP assay demonstrated a significant increase in the binding of TCF7L2 protein to the Gαi3 promoter region, as predicted in the JASPAR database, across various pancreatic cancer cells (Fig. 8G). The gene discussed is TCF7L2; the disease is familial pancreatic carcinoma.